Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSC. Asunaprevir, beclabuvir and daclatasvir fixed dose combination for hepatitis C virus infection, genotype 1 – first or second line. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC). Horizon Scanning Review. 2015 Indexing Status Subject indexing assigned by CRD MeSH Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronics; Liver Cirrhosis; Nucleic Acid Synthesis Inhibitors; Protease Inhibitors; RNA, Viral; Recombinant Proteins; Viral Nonstructural Proteins Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence NIHR Horizon Scanning Centre, School of Health&Population Sciences, University of Birmingham, Public Health building, Edgbaston, Birmingham, B15 2TT. Tel: +44 121 414 7831 Email: nihrhsc@contacts.bham.ac.uk AccessionNumber 32015000137 Date abstract record published 23/02/2015 |